Considering that, we speculate promoter methylation to be one of the reasons for inactivation of neogenin expression in gliomas, high-grade gliomas in particular, resulting in insufficiency of neogenin at the cell membrane hence alter physiological functions working to the advantage of glioma genesis and/or progression. This evidence concerns the gene NEO1 and central nervous system cancer.